Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Best Peptides to Reduce Inflammation Naturally Ranked: Mechanism Comparison

BPC-157 Upregulates VEGF and FGF in damaged tissue; accelerates wound closure and reduces inflammatory cytokine duration IL-6 reduced 50% within 72 hours in soft tissue models Localized soft tissue injuries: tendons, ligaments, muscle strains, gastrointestinal

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • BPC-157
  • Upregulates VEGF and FGF in damaged tissue; accelerates wound closure and reduces inflammatory cytokine duration
  • IL-6 reduced 50% within 72 hours in soft tissue models
  • Localized soft tissue injuries: tendons, ligaments, muscle strains, gastrointestinal inflammation
  • 250–500mcg daily subcutaneous for 4–6 weeks
  • Most versatile for acute localized inflammation. Fastest measurable effect
  • TB-500
  • Promotes actin polymerization and cellular migration; increases angiogenesis in ischemic tissue
  • Angiogenesis increased 35–40% in hypoxic models; systemic inflammation markers reduced 30–45%
  • Systemic inflammation with poor blood flow; cardiovascular tissue repair; chronic tendon issues
  • Loading: 2–2.5mg twice weekly for 4 weeks; Maintenance: 2mg weekly
  • Best for systemic and cardiovascular inflammation. Slower but broader tissue impact
  • Thymalin
  • Modulates T-cell differentiation; shifts Th1/Th2 balance to reduce autoimmune-driven inflammation
  • CRP levels reduced 30–45% over 4–6 weeks
  • Autoimmune-driven chronic inflammation; immune dysregulation conditions
  • 10mg intramuscular every other day for 10 doses
  • Targets immune cause rather than symptom. Ideal for autoimmune inflammation
  • KPV
  • Inhibits NF-kB signaling; reduces inflammatory gene transcription in gut tissue
  • Colonic inflammation markers reduced 25–35% in IBD models
  • Gut-specific inflammation; inflammatory bowel conditions
  • 500mcg–1mg daily subcutaneous or oral for 4–8 weeks
  • Specialized for gastrointestinal inflammation. Less studied but promising for gut conditions